James T. Wassil
Executive VP, Chief Scientific Officer & COOMr. James T. Wassil, also known as Jim, MS, MBA, is Director of ILiAD Biotechnologies, LLC from March 2026. Mr. Wassil was Independent Director of Icosavax Inc. since June 10, 2022. He serves as Chief Operating Officer of Vaxcyte, Inc. since December 01, 2019 and serves as its Executive Vice President since March 2022. He serves as Chief Scientific Officer of Vaxcyte, Inc. since September 2026. From May 2015 to December 2019, Mr. Wassil served as Vice President and Global Health and Value Business Unit Lead, Vaccines at Pfizer Inc. From August 2008 to May2015, Mr. Wassil served as Head, Global Product Development Meningococcal Vaccines and Head, U.S. Marketing for Meningococcal Vaccines at Novartis AG Prior to joining Novartis, Mr. Wassil served as Senior Director, International Marketing at Merck & Co., Inc. Mr. Wassil has extensive experience in the development and commercialization of vaccines having spent the past three decades in positions of increasing responsibility in the vaccine divisions of Merck, Novartis and Pfizer. He worked at Pfizer, Inc as the business unit lead for Pfizer Vaccines, where he was responsible for market access, policy, pricing, tender negotiations, epidemiology and health outcomes for the full vaccine portfolio, including the pneumococcal conjugate vaccine franchise (Prevnar 13). Previously he led international marketing for the pediatric vaccine franchise at Merck Vaccines where he launched RotaTeq, a vaccine for rotavirus gastroenteritis in infants and children and held other technical and operational roles of increasing responsibility within research, manufacturing, quality, regulatory and technology transfer. In 2014, Mr. Wassil received the VIVA Award as Novartis’ top scientist in 2014 for development and approval of Bexsero®. He also was an ACE Finalist (Secretary of State Award for Corporate Excellence) for his role in conducting an effectiveness study of RotaTeq® in Nicaragua. Mr. Wassil is a Member of the Infectious Diseases Society of America. Mr. Wassil earned a Bachelor of Science degree in chemistry/biology with high honors from the University of Notre Dame and a Master of science degree in bio-organic chemistry and a master of business administration degree, both from Lehigh University.
Positions
- Company NameVaxcyte, Inc.Stock CodePCVXPositionExecutive VP, Chief Scientific Officer & COOColleagues
- GEGrant E. PickeringCo-Founder, CEO & Director
- CVCarlos V. PayaIndependent Chairman of the Board
- ALAndrew L. GuggenhimePresident & CFO
- HSHarpreet S. DhaliwalChief Technical Operations Officer
- JFJeff FairmanCo-Founder & VP of Research
- HEHalley E. GilbertIndependent Director
- ASAnnie Seibold DrapeauIndependent Director
- TLTeri LoxamIndependent Director
